Royalty Pharma plc

RPRX

$36.10

Name : Royalty Pharma plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $21,052,590,080.00

EPSttm : 2.29

Royalty Pharma plc

$36.10

0.08%

$0.03

Float Short %

6.25

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

0.14

EPS Last/This Y

2.56

EPS This/Next Y

0.54

Price

36.12

Target Price

44.29

Analyst Recom

1.44

Performance Q

1.75

Relative Volume

0.6

Beta

0.55

Ticker: RPRX

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	RPRX	35.81	0.23	21.08	24439
2025-09-09	RPRX	36.51	0.21	0.00	23973
2025-09-10	RPRX	36.18	0.21	0.04	24254
2025-09-11	RPRX	36.69	0.21	0.79	24236
2025-09-12	RPRX	36.38	0.21	0.05	24275
2025-09-15	RPRX	35.17	0.21	2.64	24281
2025-09-16	RPRX	35.43	0.20	0.08	23887
2025-09-17	RPRX	35.64	0.2006930842248	0.012658227848101	23907
2025-09-18	RPRX	35.74	0.20	0.01	23850
2025-09-22	RPRX	35.87	0.17	0.09	21542
2025-09-23	RPRX	36.24	0.17	1.08	21502
2025-09-24	RPRX	35.77	0.17	0.13	21621
2025-09-25	RPRX	34.9	0.17	0.03	21709
2025-09-26	RPRX	35.04	0.18	0.22	21428
2025-09-29	RPRX	35.24	0.18	0.00	21441
2025-09-30	RPRX	35.26	0.18	0.16	21471
2025-10-01	RPRX	36.31	0.18	0.01	21471
2025-10-02	RPRX	36.48	0.17	0.04	22344
2025-10-03	RPRX	36.03	0.17	0.75	22356
2025-10-06	RPRX	36.12	0.17	0.00	22381
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	RPRX	35.80	0.7	409.9	4.48
2025-09-09	RPRX	36.51	0.7	454.8	4.48
2025-09-10	RPRX	36.18	0.7	407.7	4.48
2025-09-11	RPRX	36.70	0.7	446.3	4.48
2025-09-12	RPRX	36.38	0.7	407.7	4.48
2025-09-15	RPRX	35.17	0.3	367.7	4.48
2025-09-16	RPRX	35.42	0.3	435.1	4.48
2025-09-17	RPRX	35.66	0.3	453.9	4.48
2025-09-18	RPRX	35.74	0.3	447.3	4.48
2025-09-19	RPRX	36.26	0.2	466.5	4.48
2025-09-22	RPRX	35.86	0.2	424.0	4.48
2025-09-23	RPRX	36.25	0.2	460.8	4.48
2025-09-24	RPRX	35.77	0.2	420.9	4.48
2025-09-25	RPRX	34.90	0.2	402.0	4.48
2025-09-26	RPRX	35.04	0.2	449.3	4.48
2025-09-29	RPRX	35.24	0.2	452.1	4.48
2025-09-30	RPRX	35.26	0.2	443.3	4.48
2025-10-01	RPRX	36.31	0.2	491.0	4.48
2025-10-02	RPRX	36.42	0.2	447.4	4.48
2025-10-03	RPRX	36.05	0.2	422.4	4.48
2025-10-06	RPRX	36.12	0.2	425.6	4.48
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	RPRX	-0.03	4.30	4.13
2025-09-09	RPRX	-0.03	4.30	4.13
2025-09-10	RPRX	-0.03	4.30	4.13
2025-09-11	RPRX	-0.03	4.30	4.88
2025-09-12	RPRX	-0.03	4.30	4.88
2025-09-15	RPRX	-0.04	4.29	4.88
2025-09-16	RPRX	-0.04	4.29	4.88
2025-09-17	RPRX	-0.03	4.29	4.88
2025-09-18	RPRX	-0.03	4.29	4.88
2025-09-19	RPRX	-0.03	4.29	4.88
2025-09-22	RPRX	-0.03	4.29	4.88
2025-09-23	RPRX	-0.03	4.29	4.88
2025-09-24	RPRX	-0.03	4.29	4.88
2025-09-25	RPRX	-0.03	4.29	6.25
2025-09-26	RPRX	-0.03	4.29	6.25
2025-09-29	RPRX	-0.03	4.28	6.25
2025-09-30	RPRX	-0.03	4.28	6.25
2025-10-01	RPRX	-0.03	4.28	6.25
2025-10-02	RPRX	-0.03	4.28	6.25
2025-10-03	RPRX	-0.03	4.28	6.25
2025-10-06	RPRX	-0.03	3.93	6.25
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.14

Avg. EPS Est. Current Quarter

1.04

Avg. EPS Est. Next Quarter

1.28

Insider Transactions

-0.03

Institutional Transactions

3.93

Beta

0.55

Average Sales Estimate Current Quarter

756

Average Sales Estimate Next Quarter

796

Fair Value

48.45

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

32.1

Max Drawdown 5-Year %

-49.7

Target Price

44.29

P/E

15.73

Forward P/E

7.53

PEG

1.79

P/S

9.14

P/B

2.46

P/Free Cash Flow

8.36

EPS

2.3

Average EPS Est. Cur. Y

4.48

EPS Next Y. (Est.)

5.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

44.26

Relative Volume

0.6

Return on Equity vs Sector %

-9

Return on Equity vs Industry %

4.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

425.6

Royalty Pharma plc

Sector: Healthcare

Industry: Biotechnology

Employees:

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

stock quote shares RPRX – Royalty Pharma plc Stock Price stock today

news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025

marketwatch RPRX – Royalty Pharma plc yahoo finance google finance

stock history RPRX – Royalty Pharma plc invest stock market

stock prices RPRX premarket after hours

ticker RPRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: RPRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y